Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry

NCT01611337 | Completed

• 1 other identifier: 2012-A00155-38
• Study Type: interventional
• Target: 205
• Locations: 1 country
• Sites: 2

Brief Summary

Therapeutic alliance, and drug observance are major difficulties in the care of persons presenting schizophrenic symptomatology. They appear to be linked to insight, the consciousness that one has of his troubles. Nurse care in psychiatry aims at improving it, but usually without using specific evaluation tool. Insight is usually not evaluated during care, and its evolution is also not known, although it is highly probable that a positive evolution of insight for a person in hospital correlated to an adapted and optimal care by the medical and nursing teams. The investigators do not know examples of insight evaluation during a sequence of hospital care, or any evidence of insight variation in relation to evolution abilities of some schizophrenic patients cared in hospital. The investigators propose here to evaluate insight in people presenting schizophrenia or related troubles, at the beginning of hospitalization (I1) and 1 month later (I2), to better characterize insight variations, and identify the sociodemographic, clinical and therapeutic variables linked to it.

Conditions

Schizophrenia

Keywords

schizophrenia, insight

Outcome Measures

Primary Outcomes (1)

• number of collected data explaining insight variation between the first week of hospitalization (I1) and 1 month later (I2) in a model of logistic regression

  identification of the variables explaining insight variation when it is ≥ 1,5: social and demographic data : age, gender, marital status, study level clinical : disease duration, Positive and Negative Syndrome Scale (PANSS), type of trouble therapeutic : care and treatments received during hospitalization.

  first month after hospitalization

Study Arms (1)

insight evaluation

OTHER

insight evaluation using the Q8 scale

Other: insight variation measure

Interventions

insight variation measure OTHER

insight variation between the firt week of hospitalization and 1 month later

insight evaluation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of schizophrenia,
• Persons requiring psychiatric care in one of the participating care unit
• I1 \< 6 (absent or bad consciousness of the trouble).

You may not qualify if:

• I1≥6
• Expression capacities incompatible with Q8 scale quotation (delirium, no understanding of the french language, mutism, contention or therapeutic isolation)
• Age under 18, absence of health care insurance

Sponsors & Collaborators

• Centre Hospitalier Esquirol: lead

Study Sites (2)

Centre Hospitalier Esquirol

Limoges, 87000, France

Location

Centre Hospitalier La Vallette

Saint-Vaury, 23320, France

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders

Study Officials

• Danielle Bourlot, MD

  Centre Hospitalier Esquirol

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD, Head of Esquirol Hospital Medical Council

Study Record Dates

• First Submitted: May 29, 2012
• First Posted: June 4, 2012
• Study Start: June 1, 2012
• Primary Completion: July 1, 2017
• Study Completion: July 1, 2017
• Last Updated: September 19, 2017

Record last verified: 2017-09

Locations

FR (2)